Prospect: information for the patient
Bilastina Teva 10 mg buccal dispersible tabletsEFG
Read this prospect carefully before starting to take this medication,because it contains important information for you.
-This medication has been prescribed only to you or your child. Do not give it to other people, even if they have the same symptoms as you, as it may harm them.
1.What is Bilastina Teva and what is it used for
2.What you need to know before starting to take Bilastina Teva
3.How to take Bilastina Teva
4.Possible adverse effects
5Storage of Bilastina Teva
6.Contents of the package and additional information
Bilastina Teva contains bilastine as the active ingredient, which is an antihistamine.
Bilastine is used to relieve symptoms of allergic rhinoconjunctivitis (stuffy or runny nose, sneezing, itchy nose, nasal congestion, and red, watery eyes) and other forms of allergic rhinitis. It may also be used to treat itchy skin rashes (hives or urticaria).
Bilastina Teva 10 mg orally disintegrating tablets is indicated for children aged 6 years and above with a minimum body weight of 20 kg, as well as for adults and adolescents.
Do not take Bilastina Teva:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Bilastina Teva if you or your child has moderate or severe renal or hepatic insufficiency, low levels of potassium, magnesium, or calcium in the blood, if you have or have had heart rhythm problems or if your heart rate is very low, if you are taking medications that can affect heart rhythm, if you have or have had a certain abnormal heart rhythm pattern (known as QTc prolongation in the electrocardiogram) that may occur in some forms of heart disease, or if you or your child is taking other medications (see “Other medications and Bilastina Teva”).
Children
Do not administer this medication to children under 6 years of age with a body weight less than 20 kg since there are not enough data available.
Other medications and Bilastina Teva
Inform your doctor or pharmacist if you or your child is taking, has taken recently, or may need to take any other medication.
Some medications should not be taken together and other medications may require a dose adjustment when taken together.
Always inform your doctor or pharmacist if you or your child is taking or receiving any of the following medications in addition to Bilastina Teva:
Taking Bilastina Teva with food, drinks, and alcohol
These tablets should not be taken with food or with grapefruit juice or other fruit juices, as this would decrease the effect of bilastina. To avoid this, you can:
Bilastina, at the recommended dose in adults (20 mg), does not increase the drowsiness caused by alcohol.
Pregnancy, breastfeeding, and fertility
There are no data or these are very limited on the use of bilastina in pregnant women and during breastfeeding, and on the effects on fertility.
If you are pregnant or breastfeeding, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Consult your doctor or pharmacist before taking any medication.
Driving and operating machinery
It has been demonstrated that bilastina 20 mg does not affect performance during driving in adults.
However, the response of each patient to the medication may be different.
Therefore, check how this medication affects you or your child before driving, operating machinery, or riding a bicycle.
Bilastina Teva contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per buccal dispersible tablet; this is, essentially “sodium-free”.
Bilastina Teva contains sulfur dioxide
This medication contains sulfur dioxide. Rarely, it may cause severe hypersensitivity reactions and bronchospasm.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist.This medicationindicated by your doctor or pharmacist.Consult your doctor or pharmacist again in case of doubt.
Use in adults and adolescents 12 years and older
The recommended dose in adults, including elderly people and adolescents 12 years and older, is 20 mg (two 10 mg tablets) once a day.
Use in children
The recommended dose in children 6 to 11 years of age with a minimum body weight of 20 kg is one 10 mg tablet once a day. Do not administer this medication to children under 6 years of age with a body weight less than 20 kg since there are not enough data available.
Since the duration of treatment depends on the underlying disease of you or your child, your doctor will determine for how long you should take Bilastina Teva.
If you take more Bilastina Teva than you should
If you or your child exceed the dose of this medication, inform your doctor immediately or go to the nearest hospital emergency service. Please remember to bring this medication package or this leaflet with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Bilastina Teva
Do nottake a double dose to compensate for the missed doses.
If you forget to administer the daily dose to your child on time, administer it the same day as soon as you notice. Then, administer the next dose the following day at the usual time as indicated by your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
If you interrupt treatment with Bilastina Teva
Generally, there will be no effectsafter abandoningthe treatment with Bilastina Teva.
If you have any other questions about the use of thismedication, ask your doctor,orpharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
If you or your child experiencesallergic reactions whose symptoms may include difficulty breathing, dizziness, fainting, or loss of consciousness, swelling of the face, lips, tongue, or throat, and/or swelling and redness of the skin, stop administering this medicine and seek immediate medical attention.
Other side effects that may appearin children:
Frequent: may affect up to 1 in 10 people
Less frequent: may affect up to 1 in 100 people
Side effects that may appearin adults and adolescents:
Frequent: may affect up to 1 in 10 people
Less frequent: may affect up to 1 in 100 people
Unknown frequency: cannot be estimated from available data
Reporting side effects
If your child experiences any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keepthis medicationout of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears on thecontainerand on the blister pack after CAD/EXP. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash.Deposit the containers and medications you no longer need at the Sigre Point of the pharmacy.In case of doubtask your pharmacisthow to dispose ofthecontainers and themedications you no longerneed.By doing so, you will help protect the environment.
Composition of Bilastina Teva
Each tablet contains 10 mg of bilastina.
Manitol (E 421), microcrystalline cellulose, sodium croscarmellose (see section 2 “Bilastina Teva contains sodium”), aluminium magnesium metasilicate, sucralose, grape aroma (see section 2 “Bilastina Teva contains sulfur dioxide”), magnesium stearate, anhydrous colloidal silica.
Appearance of the product and content of the container
Bilastina Teva 10 mg buccal tablets EFG are round, biconvex tablets, approximately 7.5 mm in size, white to off-white in color, smooth to speckled, engraved with "10" on one face and smooth on the other face.
The tablets are packaged in blisters of 10, 20, 30 or 50 tablets.
Only some package sizes may be commercially marketed.
Marketing authorization holder
Teva B.V.
Swensweg 5, 2031GA Haarlem
Netherlands
Responsible for manufacture:
Saneca Pharmaceuticals a.s.
Nitrianska 100 920 27 Hlohovec
Slovak Republic
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11 Edificio Albatros B 1st floor
28108 Alcobendas – Madrid (Spain)
Last revision date of thisleaflet:March 2025
The detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.